Wise Practice of Chinese Hemodialysis (WISHES)
Study Details
Study Description
Brief Summary
The investigators are registering all HD patients at recruited hospitals and developing a HD database in China. Patients will be follow-up every 3 months, and both baseline and follow-up information will be entered into the registration system. The patient survival, technical survival, patency rate of access, quality of life and residual renal function for HD patients will be compared using the HD database.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The investigators are registering all end stage renal disease (ESRD) patients receiving hemodialysis (HD) treatment, and developing a HD database in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and education), clinical characteristics (including systolic blood pressure, diastolic blood pressure, primary cause of ESRD, and lab measurements of serum, urine, and access patency), complications, drug information and scores of quality of life at the baseline will be collected. Patients will be follow-up every 3 month, the demographic and clinical characteristics, complications and drug information of patients will be collected at each visit. The investigators also record the outcome at each visit, such as mortality (including all-cause mortality and cardiovascular disease mortality), technical survival, kidney transplantation, transfer to peritoneal dialysis, hospitalization, access failure，etc. The patient survival, technical survival, patency rate of access, quality of life and residual renal function for HD patients will be compared using the HD database.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Hemodialysis patients End stage renal disease patients receiving hemodialysis treatment |
Other: No intervention
Registration of all HD patients in the First Affiliated Hospital of Sun Yat-sen University and other hospital which have signed the contract in China.
|
Outcome Measures
Primary Outcome Measures
- Patient survival of HD patients [10 years]
Secondary Outcome Measures
- Quality of life evaluated using SF36 scale for HD patients [10 years]
- Patency rate of access for HD patients [10 years]
Eligibility Criteria
Criteria
Inclusion Criteria:
End stage renal disease patients receiving hemodialysis treatment.
Exclusion Criteria:
No
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | The 1st Affiliated Hospital, Sun Yet-sen University | Guangzhou | Guangdong | China | 510080 |
Sponsors and Collaborators
- Sun Yat-sen University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- WISHES